The Tryton Side Branch Stent™ for the treatment of coronary bifurcation lesions

Maik J. Grundeken; Pieter R. Stella; Joanna J. Wykrzykowska

doi:https://doi.org/10.1586/17434440.2013.848165

The Tryton Side Branch Stent™ for the treatment of coronary bifurcation lesions

Maik J. Grundeken, Pieter R. Stella, Joanna J. Wykrzykowska

Cardiology (AMC)

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Abstract

Coronary bifurcation lesions account for approximately 15% of all percutaneous coronary interventions (PCI) performed. Although clinical outcomes after PCI have been improved considerably, PCI of bifurcation lesions remains to be associated with adverse clinical events, when compared with non-bifurcation PCI. Therefore, several dedicated bifurcation devices have been developed to improve clinical outcomes. The Tryton Side Branch Stent(™) is such device and is used in combination with a regular tubular balloon expandable stent in the main branch. Multiple single and multicenter registries and a patient pooled analysis including 900 patients have shown promising results regarding clinical outcomes after bifurcation PCI with Tryton. The pivotal Tryton IDE randomized trial is currently underway comparing the Tryton stent with side branch balloon angioplasty as side branch treatment in bifurcation lesions challenging the current dogma of provisional single stent strategy as treatment for coronary bifurcation lesions

Original language	English
Pages (from-to)	707-716
Journal	Expert review of medical devices
Volume	10
Issue number	6
DOIs	https://doi.org/10.1586/17434440.2013.848165
Publication status	Published - 2013

Access to Document

https://doi.org/10.1586/17434440.2013.848165

Cite this

@article{742b6f6fa20b4dcf8750925885cb97c8,

title = "The Tryton Side Branch Stent{\texttrademark} for the treatment of coronary bifurcation lesions",

abstract = "Coronary bifurcation lesions account for approximately 15% of all percutaneous coronary interventions (PCI) performed. Although clinical outcomes after PCI have been improved considerably, PCI of bifurcation lesions remains to be associated with adverse clinical events, when compared with non-bifurcation PCI. Therefore, several dedicated bifurcation devices have been developed to improve clinical outcomes. The Tryton Side Branch Stent({\texttrademark}) is such device and is used in combination with a regular tubular balloon expandable stent in the main branch. Multiple single and multicenter registries and a patient pooled analysis including 900 patients have shown promising results regarding clinical outcomes after bifurcation PCI with Tryton. The pivotal Tryton IDE randomized trial is currently underway comparing the Tryton stent with side branch balloon angioplasty as side branch treatment in bifurcation lesions challenging the current dogma of provisional single stent strategy as treatment for coronary bifurcation lesions",

author = "Grundeken, {Maik J.} and Stella, {Pieter R.} and Wykrzykowska, {Joanna J.}",

year = "2013",

doi = "https://doi.org/10.1586/17434440.2013.848165",

language = "English",

volume = "10",

pages = "707--716",

journal = "Expert review of medical devices",

issn = "1743-4440",

publisher = "Taylor & Francis",

number = "6",

}

TY - JOUR

T1 - The Tryton Side Branch Stent™ for the treatment of coronary bifurcation lesions

AU - Grundeken, Maik J.

AU - Stella, Pieter R.

AU - Wykrzykowska, Joanna J.

PY - 2013

Y1 - 2013

N2 - Coronary bifurcation lesions account for approximately 15% of all percutaneous coronary interventions (PCI) performed. Although clinical outcomes after PCI have been improved considerably, PCI of bifurcation lesions remains to be associated with adverse clinical events, when compared with non-bifurcation PCI. Therefore, several dedicated bifurcation devices have been developed to improve clinical outcomes. The Tryton Side Branch Stent(™) is such device and is used in combination with a regular tubular balloon expandable stent in the main branch. Multiple single and multicenter registries and a patient pooled analysis including 900 patients have shown promising results regarding clinical outcomes after bifurcation PCI with Tryton. The pivotal Tryton IDE randomized trial is currently underway comparing the Tryton stent with side branch balloon angioplasty as side branch treatment in bifurcation lesions challenging the current dogma of provisional single stent strategy as treatment for coronary bifurcation lesions

AB - Coronary bifurcation lesions account for approximately 15% of all percutaneous coronary interventions (PCI) performed. Although clinical outcomes after PCI have been improved considerably, PCI of bifurcation lesions remains to be associated with adverse clinical events, when compared with non-bifurcation PCI. Therefore, several dedicated bifurcation devices have been developed to improve clinical outcomes. The Tryton Side Branch Stent(™) is such device and is used in combination with a regular tubular balloon expandable stent in the main branch. Multiple single and multicenter registries and a patient pooled analysis including 900 patients have shown promising results regarding clinical outcomes after bifurcation PCI with Tryton. The pivotal Tryton IDE randomized trial is currently underway comparing the Tryton stent with side branch balloon angioplasty as side branch treatment in bifurcation lesions challenging the current dogma of provisional single stent strategy as treatment for coronary bifurcation lesions

U2 - https://doi.org/10.1586/17434440.2013.848165

DO - https://doi.org/10.1586/17434440.2013.848165

M3 - Article

C2 - 24164662

SN - 1743-4440

VL - 10

SP - 707

EP - 716

JO - Expert review of medical devices

JF - Expert review of medical devices

IS - 6

ER -